<ORGANIZATION>Quest Biotechnology Inc</ORGANIZATION> said its <ORGANIZATION>Quest Blood Substitute Inc</ORGANIZATION> subsidiary executed an agreement with <ORGANIZATION>Alza Corp AZA</ORGANIZATION> which will make <ORGANIZATION>Alza</ORGANIZATION> a preferred shareholder of its subsidiary .
<ORGANIZATION>Quest</ORGANIZATION> said the agreement also offers <ORGANIZATION>Alza</ORGANIZATION> the right to acquire up to 25 pct of the unit 's equity in exchange for the acquisition of patent rights to <ORGANIZATION>Alza</ORGANIZATION> technology in an area where <ORGANIZATION>Quest</ORGANIZATION> has an interest .
<ORGANIZATION>Quest</ORGANIZATION> also said its signed a merger agreement with < <ORGANIZATION>Hunt Research Corp</ORGANIZATION> > and its affiliate <ORGANIZATION>ICAS Corp.</ORGANIZATION> .
<ORGANIZATION>Quest</ORGANIZATION> said it expects to complete the merger within the next several weeks .
